Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
Autor: | Soileau, Michael J *, Aldred, Jason, Budur, Kumar, Fisseha, Nahome, Fung, Victor SC, Jeong, Anna, Kimber, Thomas E, Klos, Kevin, Litvan, Irene, O'Neill, Daniel, Robieson, Weining Z, Spindler, Meredith A, Standaert, David G, Talapala, Saritha, Vaou, Eleni Okeanis, Zheng, Hui, Facheris, Maurizio F, Hauser, Robert A |
---|---|
Zdroj: | In The Lancet Neurology December 2022 21(12):1099-1109 |
Databáze: | ScienceDirect |
Externí odkaz: |